HAEMONETICS CORP's ticker is HAE and the CUSIP is 405024100. A total of 288 filers reported holding HAEMONETICS CORP in Q4 2020. The put-call ratio across all filers is 1.18 and the average weighting 0.1%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $1,068,360 | +14.8% | 11,926 | +9.1% | 0.01% | +16.7% |
| Q2 2023 | $930,816 | +49.2% | 10,933 | +52.8% | 0.01% | -7.7% |
| Q3 2020 | $624,000 | -46.0% | 7,154 | -44.5% | 0.01% | -48.0% |
| Q2 2020 | $1,155,000 | -20.4% | 12,894 | -11.5% | 0.02% | -30.6% |
| Q1 2020 | $1,451,000 | -17.1% | 14,562 | -4.4% | 0.04% | +9.1% |
| Q4 2019 | $1,750,000 | -22.5% | 15,232 | -14.9% | 0.03% | -26.7% |
| Q3 2019 | $2,257,000 | +87.8% | 17,895 | +79.1% | 0.04% | +80.0% |
| Q2 2019 | $1,202,000 | +115.4% | 9,989 | -24.6% | 0.02% | +13.6% |
| Q4 2013 | $558,000 | -32.6% | 13,246 | -36.2% | 0.02% | -38.9% |
| Q3 2013 | $828,000 | +1.8% | 20,760 | +5.5% | 0.04% | -2.7% |
| Q2 2013 | $813,000 | – | 19,672 | – | 0.04% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Millrace Asset Group, Inc. | 19,264 | $1,726 | 2.13% |
| Parkman Healthcare Partners LLC | 88,962 | $7,969,216 | 1.46% |
| HEARTLAND ADVISORS INC | 256,414 | $24,435,274 | 1.37% |
| Riverwater Partners LLC | 15,553 | $1,393,238 | 1.27% |
| KINGDON CAPITAL MANAGEMENT, L.L.C. | 111,100 | $9,952,338 | 1.15% |
| Lisanti Capital Growth, LLC | 78,425 | $7,025,312 | 1.11% |
| Aristotle Capital Boston, LLC | 311,666 | $27,919,054 | 0.90% |
| ROYCE & ASSOCIATES LP | 947,550 | $84,881,529 | 0.86% |
| CHASE INVESTMENT COUNSEL CORP | 18,770 | $1,681 | 0.84% |
| Virtus Investment Advisers, Inc. | 13,662 | $1,223,842 | 0.83% |